↑ 疾患リストへ ← 戻る

 316. カルニチン回路異常症 [臨床試験数:3,薬物数:10(DrugBank:4),標的遺伝子数:2,標的パスウェイ数:8] 

Searched query = "Carnitine cycle disorder", "Carnitine palmitoyltransferase I deficiency", "CPT1 deficiency", "Carnitine palmitoyltransferase II deficiency", "CPT2 deficiency", "Carnitine-acylcarnitine translocase deficiency", "CACT deficiency", "Carnitine transporter deficiency", "OCTN-2 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"    Synonyms (DrugBank) were also searched for.
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02517307February 201629 July 2019Fatty Acid Oxidation Defects and Insulin SensitivityRole of Fatty Acid Oxidation Defects in Insulin SensitivityVery Long-chain Acyl-CoA Dehydrogenase Deficiency;Trifunctional Protein Deficiency;Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Medium-chain Acyl-CoA Dehydrogenase Deficiency;Normal Volunteers;Carnitine Palmitoyltransferase II Deficiency, MyopathicDrug: Intralipid/Heparin;Drug: Glycerol/Saline;Drug: Hyperinsulinemic euglycemic clampOregon Health and Science UniversityRecruiting18 YearsN/AAll50N/AUnited States
2NCT02226419August 201325 May 2015Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter DeficiencyFat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter DeficiencyCarnitine Transporter, Plasma-membrane, Deficiency ofDietary Supplement: Break in L-carnitine treatmentKaren Lindhardt MadsenRigshospitalet, DenmarkNot recruiting18 YearsN/ABoth14N/A
3NCT00336167June 200619 February 2015Bezafibrate Trial in CPT2 DeficiencyClinical Trial on the Effect of Bezafibrate in the Muscular Form of Carnitine Palmitoyltransferase 2 DeficiencyCarnitine Palmitoyl Transferase 2 DeficiencyDrug: bezafibrate (drug)Assistance Publique - Hôpitaux de ParisAssociation Française contre les Myopathies (AFM), Paris;Institut National de la Santé Et de la Recherche Médicale, FranceRecruiting18 YearsN/ABoth12Phase 3France